-->

Tag: Myelodysplastic syndromes treatment

Home / Myelodysplastic syndromes treatment

Categories

Imetelstat is approved by FDA for low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia

  May 2024: Imetelstat (Rytelo, Geron Corporation), an oligonucleotide telomerase inhibitor, has been approved by the Food and Drug Administration for use in adults with low- to intermediate-1...
myelodysplastic-syndromes-treatment

Ivosidenib is approved by FDA for myelodysplastic syndromes

Nov 2023: The Food and Drug Administration (FDA) approved Ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) in November 2023 for the treatment of adult patients with relapsed or refractory myelod...
myelodysplastic-syndromes-treatment

myelodysplastic syndromes 


myelodysplastic-syndromes-treatment

We Are Online! Chat With Us!
Scan the code